Fig. 3

Transition of the serum alfa-fetoprotein level during the treatment course. AFP, alfa-fetoprotein; Ate/bev, atezolizumab plus bevacizumab treatment; Ate, atezolizumab treatment
Transition of the serum alfa-fetoprotein level during the treatment course. AFP, alfa-fetoprotein; Ate/bev, atezolizumab plus bevacizumab treatment; Ate, atezolizumab treatment